在转移性割抵抗性前列腺癌中,双特异性T细胞参与者
Chadi Hage Chehade1, Georges Gebrael1, Neeraj Agarwal1
1Huntsman Cancer Institute, University of Utah (NCI-CCC), Salt Lake City, Utah.
Cancer discovery
|January 12, 2024
概括
针对STEAP1的双特异性T细胞参与者在转移性前列腺癌中表现有前途. 这些新型药物提供了一种新的治疗途径,而其他免疫疗法只有有限的成功.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 前列腺癌研究 研究前列腺癌
背景情况:
- 转移性前列腺癌仍然是一个挑战,目前免疫向剂的治疗益处有限.
- 需要新的治疗策略来改善晚期疾病患者的治疗结果.
研究的目的:
- 评估双特异性T细胞参与者的潜力,特别是那些针对STEAP1的,作为转移性前列腺癌的治疗方法.
主要方法:
- 对STEAP1-向双特异性T细胞诱导剂的临床前数据和早期临床试验结果的审查.
主要成果:
- 在临床前模型和I期研究中观察到令人鼓舞的疗效信号.
- 作为一种新的治疗方法,STEAP1双特异性T细胞吸引剂显示出潜在的潜力.
结论:
- 针对STEAP1的双特异性T细胞参与者代表了转移性前列腺癌的有希望的新治疗选择.
- 需要进一步的研究来确定它们在临床实践中的作用.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
10:19Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
Published on: May 12, 2023
1.3K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K